Blog — Center for Communication Compliance

The Latest Guidance From FDA on DTC Advertising: Is Greater Enforcement Next?

The Latest Guidance From FDA on DTC Advertising: Is Greater Enforcement Next?

Ilyssa LevinsFebruary 12, 2024

A Short Brush Up on Risk Evaluation and Mitigation Strategy

A Short Brush Up on Risk Evaluation and Mitigation Strategy

Ilyssa LevinsOctober 26, 2023

Create a Culture of Trust to Fuel Innovative Thinking in Our Regulated Industry

Create a Culture of Trust to Fuel Innovative Thinking in Our Regulated Industry

Ilyssa LevinsOctober 2, 2023

Another FDA Letter is Harbinger of Increased Enforcement in 2023

Another FDA Letter is Harbinger of Increased Enforcement in 2023

Ilyssa LevinsAugust 31, 2023

New 2023 FDA Guidance Released for DTC Promotional Labeling and Advertisements

New 2023 FDA Guidance Released for DTC Promotional Labeling and Advertisements

Ilyssa LevinsJuly 19, 2023

Xeris Pharmaceuticals Receives First Enforcement Letter of 2023 - “One Off” or Beginning of a New Trend?

Xeris Pharmaceuticals Receives First Enforcement Letter of 2023 - “One Off” or Beginning of a New Trend?

Ilyssa LevinsJune 16, 2023

Preparing for Increased Government Enforcement

Preparing for Increased Government Enforcement

Ilyssa LevinsApril 17, 2023

STATISTICS SUGGEST THAT ENFORCEMENT WILL BE A TOP GOVERNMENT PRIORITY IN 2023

STATISTICS SUGGEST THAT ENFORCEMENT WILL BE A TOP GOVERNMENT PRIORITY IN 2023

Ilyssa LevinsMarch 7, 2023Comment

Survey of MLR Reviewers Demonstrates That Not Much Has Changed: Part 2

Survey of MLR Reviewers Demonstrates That Not Much Has Changed: Part 2

Ilyssa LevinsMarch 6, 2023Comment

Survey of MLR Reviewers Demonstrates That Not Much Has Changed

Survey of MLR Reviewers Demonstrates That Not Much Has Changed

Ilyssa LevinsMarch 1, 2023Comment